Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics, Pharmacogenomics Providers May Benefit From $30M Gift to UCSD Pharmacy School

NEW YORK, Nov. 5 (GenomeWeb News) - The University of California, San Diego has received a $30 million gift from The Skaggs Institute for Research to help support its School of Pharmacy and Pharmaceutical Sciences, UCSD said yesterday.

 

The school's research program "emphasizes" pharmacogenomics, bioinformatics, and computational drug design. UCSD will use the money, payable over the next five years, to recruit pharmaceutical scientists and pharmacy practitioners.

 

The gift, which the university said is the largest ever to UCSD Health Sciences, will provide $10 million to help recruit faculty and buy equipment. In addition, a $20-million endowment will be established. The school initially plans to use the endowment to hire faculty and recruit students, UCSD said.

In return, UCSD will rename the school The Skaggs School of Pharmacy and Pharmaceutical Sciences.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.